케토코나졸 시장 : 현황 분석과 예측(2023-2030년)

Ketoconazole is an antifungal medication used to treat various fungal infections like athlete's foot, ringworm, and yeast infections. It's available in different forms like shampoo, cream, and oral tablets. It works by inhibiting the growth of fungi. However, it's essential to use it as prescribed by a healthcare professional due to potential side effects and interactions with other medications. The ketoconazole market is growing at a tremendous rate owing to the higher cases of skin problems. Other factors such as the increased utilization of ketoconazole in the healthcare industry due to the rise in fungal infections, the growing awareness among consumers regarding health concerns, and a rise in the urban population are driving factors for the market.

The Ketoconazole Market is expected to grow at a strong CAGR of 3.1% during the forecast period owing to the rising partnerships and acquisitions. For instance, in September 2020, Alliance exclusively partnered with Alniche to market Nizral & Nizoral (Ketoconazole, sold under the brand name Nizoral) in India. Several other factors such as an increased number of product launches, increased usage of ketoconazole in the food and pharma industry, rising population, upsurge in demand for skincare products, company collaborations, and product launches are also leading to the surge in the market. For instance, in November 2020, Sandoz shipped its first medicine Pantoprazole in collaboration with Civica Rx to supply US hospitals.

Based on product type, the market is segmented into ketoconazole oral, ketoconazole topical, and ketoconazole shampoo. The ketoconazole topical segment held the highest share of the market in the year 2022 owing to the ease of applying it on the surface. It is used to treat skin infections caused by different types of fungus and can also prevent them from coming back. Also, manufacturing topical form is easier and less expensive, which provides competitive pricing to the segment in the market. Manufacturers strive to improve their product's user experience to make it more accessible. Hence, the ketoconazole topical segment held a significant share of the market in the year 2022.

Based on application, the market is segmented into antifungal, hair loss, and others. The hair loss segment is expected to grow with the highest CAGR during the forecast period owing to rising cases of hair loss. Also, the rising demand for haircare medicines, the need for safe options for medicines, strategic collaborations and collaborations, and innovative product launches have further increased the demand for intelligent products. Thus, the hair loss segment is expected to gain prominence in the market in the forecast period.

For a better understanding of the market adoption of the ketoconazole industry, the market is analyzed based on its worldwide presence in countries such as North America (U.S., Canada, and Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America dominated the market of ketoconazoles in 2022. Several factors such as the availability of cutting-edge and innovative products, growing awareness about health concerns, the rising urban population in the region are increasing the demand for such antifungal drugs, and loaded investment in ketoconazole product discovery are driving the market in the region. North America dominated the ketoconazole market among regions in the year 2022.

Some of the major players operating in the market include: Mylan Inc.; Almirall, S.A; Johnson & Johnson Services, Inc.; Taro Pharmaceutical Industries Ltd.; Teva Pharmaceutical Industries Ltd.; Sandoz Group AG; Strides Pharma Science Limited; LGM Pharma; AKSHAR PHARMA; Gonane Pharma.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

• 1.1. Market Definitions
• 1.2. Main Objective
• 1.3. Stakeholders
• 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

• 2.1. Research Process of the Ketoconazole Market
• 2.2. Research Methodology of the Ketoconazole Market
• 2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE KETOCONAZOLE MARKET

6 KETOCONAZOLE MARKET REVENUE (USD BN), 2020-2030F

7 MARKET INSIGHTS BY PRODUCT TYPE

• 7.1. Ketoconazole Oral
• 7.2. Ketoconazole Topical
• 7.3. Ketoconazole Shampoo

8 MARKET INSIGHTS BY APPLICATION

• 8.1. Antifungal
• 8.2. Hair Loss
• 8.3. Others

9 MARKET INSIGHTS BY REGION

• 9.1. North America
  • 9.1.1. U.S.
  • 9.1.2. Canada
  • 9.1.3. Rest of North America
• 9.2. Europe
  • 9.2.1. Germany
  • 9.2.2. U.K.
  • 9.2.3. France
  • 9.2.4. Italy
  • 9.2.5. Spain
  • 9.2.6. Rest of Europe
• 9.3. Asia-Pacific
  • 9.3.1. China
  • 9.3.2. Japan
  • 9.3.3. India
  • 9.3.4. Rest of Asia-Pacific
• 9.4. Rest of World

10 KETOCONAZOLE MARKET DYNAMICS

• 10.1. Market Drivers
• 10.2. Market Challenges

11 KETOCONAZOLE MARKET OPPORTUNITIES

12 KETOCONAZOLE MARKET TRENDS

13 DEMAND AND SUPPLY-SIDE ANALYSIS

• 13.1. Demand Side Analysis
• 13.2. Supply Side Analysis

14 VALUE CHAIN ANALYSIS

15 COMPETITIVE SCENARIO

• 15.1. Competitive Landscape
  • 15.1.1. Porters Fiver Forces Analysis

16 COMPANY PROFILED

• 16.1. Mylan Inc.
• 16.2. Almirall, S.A
• 16.3. Johnson & Johnson Services, Inc.
• 16.4. Taro Pharmaceutical Industries Ltd.
• 16.5. Teva Pharmaceutical Industries Ltd.
• 16.6. Sandoz Group AG
• 16.7. Strides Pharma Science Limited.
• 16.8. LGM Pharma
• 16.9. Agrat Chemicals and Pharmaceuticals
• 16.10. AKSHAR PHARMA

17 DISCLAIMER